(Q38046777)

27 August 2017

title

Comparison of initial warfarin response in obese patients versus non-obese patients (English)

1 reference

27 August 2017

0 references

1 reference

Jessica L Wallace

1

1 reference

27 August 2017

Anne B Reaves

2

1 reference

27 August 2017

Elizabeth A Tolley

3

1 reference

27 August 2017

Carrie S Oliphant

4

1 reference

27 August 2017

Lydia Hutchison

5

1 reference

27 August 2017

Numan Abdulraman Alabdan

6

1 reference

27 August 2017

Christopher W Sands

7

1 reference

27 August 2017

Timothy H Self

8

1 reference

27 August 2017

publication date

1 July 2013

1 reference

Journal of Thrombosis and Thrombolysis

27 August 2017

published in

1 reference

27 August 2017

volume

36

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

96-101

1 reference

Frequency of adverse events in patients with poor anticoagulation: a meta-analysis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

Genetic determinants of response to warfarin during initial anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

Factors affecting warfarin requirements. A prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0811-X

Control of warfarin therapy in the elderly

21 January 2018

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are not

1 reference

12 December 2020

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

1 reference

12 December 2020

Overweight, obesity, and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

10.1007/S11239-012-0811-X

Identifiers

DOI

1 reference

27 August 2017

1 reference